Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19-associated fungal infections
Martin Hoenigl, Danila Seidel, Rosanne Sprute, et al.
Nature Microbiology (2022) Vol. 7, Iss. 8, pp. 1127-1140
Open Access | Times Cited: 327

Showing 1-25 of 327 citing articles:

Immune responses to human fungal pathogens and therapeutic prospects
Michail S. Lionakis, Rebecca A. Drummond, Tobias M. Hohl
Nature reviews. Immunology (2023) Vol. 23, Iss. 7, pp. 433-452
Open Access | Times Cited: 163
The rapid emergence of antifungal-resistant human-pathogenic fungi
Shawn R. Lockhart, Anuradha Chowdhary, Jeremy A.W. Gold
Nature Reviews Microbiology (2023) Vol. 21, Iss. 12, pp. 818-832
Closed Access | Times Cited: 110
Worldwide emergence of fluconazole-resistant Candida parapsilosis: current framework and future research roadmap
Farnaz Daneshnia, João Nóbrega de Almeida, Macit İlkit, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 6, pp. e470-e480
Open Access | Times Cited: 104
Cryptococcus neoformans, a global threat to human health
Youbao Zhao, Leixin Ye, Fujie Zhao, et al.
Infectious Diseases of Poverty (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 88
Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study
Martin Hoenigl, Jon Salmanton‐García, Matthias Egger, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 6, pp. 751-761
Open Access | Times Cited: 69
Multicenter Case–Control Study of COVID-19–Associated Mucormycosis Outbreak, India
Valliappan Muthu, Ritesh Agarwal, Shivaprakash M. Rudramurthy, et al.
Emerging infectious diseases (2023) Vol. 29, Iss. 1, pp. 8-19
Open Access | Times Cited: 46
An Overlooked and Underrated Endemic Mycosis—Talaromycosis and the Pathogenic Fungus Talaromyces marneffei
Fang Wang, Runhua Han, Shi Chen
Clinical Microbiology Reviews (2023) Vol. 36, Iss. 1
Open Access | Times Cited: 46
Invasive candidiasis
Cornelia Lass‐Flörl, Souha S. Kanj, Nelesh P. Govender, et al.
Nature Reviews Disease Primers (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 45
Fungal infections: Immune defense, immunotherapies and vaccines
Jia Tong Loh, Kong‐Peng Lam
Advanced Drug Delivery Reviews (2023) Vol. 196, pp. 114775-114775
Open Access | Times Cited: 42
Fungal microbiota sustains lasting immune activation of neutrophils and their progenitors in severe COVID-19
Takato Kusakabe, Woan-Yu Lin, Jin‐Gyu Cheong, et al.
Nature Immunology (2023) Vol. 24, Iss. 11, pp. 1879-1889
Open Access | Times Cited: 40
Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease
Martin Hoenigl, Amir Arastehfar, Maiken Cavling Arendrup, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 27
Risk factors for COVID-19-associated pulmonary aspergillosis: a systematic review and meta-analysis
Francesca Gioia, Laura N. Walti, Ani Orchanian‐Cheff, et al.
The Lancet Respiratory Medicine (2024) Vol. 12, Iss. 3, pp. 207-216
Closed Access | Times Cited: 20
New treatment options for critically important WHO fungal priority pathogens
Lisa Kriegl, Matthias Egger, Johannes Boyer, et al.
Clinical Microbiology and Infection (2024)
Open Access | Times Cited: 15
Editorial: The World Health Organization (WHO) Fungal Priority Pathogens List in Response to Emerging Fungal Pathogens During the COVID-19 Pandemic
Dinah V. Parums
Medical Science Monitor (2022) Vol. 28
Open Access | Times Cited: 55
Fungal Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management
George R. Thompson, Jeffrey D. Jenks, John W. Baddley, et al.
Clinical Microbiology Reviews (2023) Vol. 36, Iss. 3
Open Access | Times Cited: 38
The changing epidemiology of fungal infections
Cornelia Lass‐Flörl, Stephan Steixner
Molecular Aspects of Medicine (2023) Vol. 94, pp. 101215-101215
Open Access | Times Cited: 38
Pathogenicity and virulence of Aspergillus fumigatus
Kayleigh Earle, Clara Valero, Daniel P. Conn, et al.
Virulence (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 36
Immunity to fungi in the lung
Lena J. Heung, Darin L. Wiesner, Keyi Wang, et al.
Seminars in Immunology (2023) Vol. 66, pp. 101728-101728
Open Access | Times Cited: 36
Environmental reservoirs of the drug-resistant pathogenic yeast Candida auris
Ayorinde B. Akinbobola, Ryan Kean, Syed Manzoor Ahmed Hanifi, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 4, pp. e1011268-e1011268
Open Access | Times Cited: 36
Metagenomic Next-Generation Sequencing of Plasma for Diagnosis of COVID-19-Associated Pulmonary Aspergillosis
Martin Hoenigl, Matthias Egger, Jessica S. Price, et al.
Journal of Clinical Microbiology (2023) Vol. 61, Iss. 3
Open Access | Times Cited: 34
Fungal infection profile in critically ill COVID-19 patients: a prospective study at a large teaching hospital in a middle-income country
Essamedin M. Negm, Mohamed Sorour Mohamed, Rehab Ahmed Rabie, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 32
Advances in the treatment of invasive fungal disease
Zhuan Zhang, Gerald F. Bills, Zhiqiang An
PLoS Pathogens (2023) Vol. 19, Iss. 5, pp. e1011322-e1011322
Open Access | Times Cited: 30
Race and ethnicity: Risk factors for fungal infections?
Jeffrey D. Jenks, Chioma Inyang Aneke, Mohanad Al‐Obaidi, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 1, pp. e1011025-e1011025
Open Access | Times Cited: 29
Treatment of Invasive Aspergillosis: How It’s Going, Where It’s Heading
Johannes Boyer, Simon Feys, Isabella Zsifkovits, et al.
Mycopathologia (2023) Vol. 188, Iss. 5, pp. 667-681
Open Access | Times Cited: 29
Molecular characterization of Candida auris outbreak isolates in Qatar from patients with COVID-19 reveals the emergence of isolates resistant to three classes of antifungal drugs
Fatma Ben Abid, Husam Salah, Sathyavathi Sundararaju, et al.
Clinical Microbiology and Infection (2023) Vol. 29, Iss. 8, pp. 1083.e1-1083.e7
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top